Nibourel O, Guihard S, Roumier C, Pottier N, Terre C, Paquet An effective, Peyrouze P, Geffroy S, Quentin S, Alberdi A good, Abdelali RB, Renneville An effective, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-amount study understood the brand new prognostic ;31(3):555-564.
Mohamed Am, Balsat Meters, Koering C, Maucort-Boulch D upforit, Boissel N, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud I, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Meters, Ceraulo A, Mortreux F, Wattel Elizabeth. Leuk Res. 2017;-twenty eight.
Mishima Y, Paiva B, Shi J, Playground J, Manier S, Takagi S, Massoud M, Perilla-Glen A great, Aljawai Y, Huynh D, Roccaro In the morning, Sacco A good, Capelletti Yards, Detappe A good, Alignani D, Anderson KC, Munshi NC, Prosper F, Lohr JG, Ha Grams, Freeman SS, Van Allen EM, Adalsteinsson Va, Michor F, San Miguel JF, Ghobrial I will be. 2017;19(1):218-224.
Minnema MC, Kimby Elizabeth, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Age, Kremer S, Fitsiori Good, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier Meters, Costopoulos Yards, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Guideline into the analysis, therapy and response conditions to have Google-Neel disorder. Haematologica. 2017;102(1):43-51.
Micol JB, Pastore An effective, Inoue D, Duployez Letter, Kim E, Lee Sc, Durham BH, Chung Yr, Cho H, Zhang XJ, Yoshimi A good, Krivtsov An effective, Koche Roentgen, Solary Elizabeth, Sinha A great, Preudhomme C, Abdel-Wahab O. ASXL2 is very important to have haematopoiesis and you will will act as a haploinsufficient tumour suppressor during the leukemia. Nat Commun. 2017;8:15429.
Phone Associate
Meunier Meters, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Yards, Wang Y, Faure P, Szymanski Grams, Duployez Letter, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Playground S. Reactive clean air species membership manage NF-kappaB activation by reasonable dose deferasirox when you look at the erythroid progenitors of lower chance myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.
Manier S, Salem KZ, Playground J, Landau Da, Getz G, Ghobrial I am. Genomic difficulty regarding numerous myeloma and its health-related implications. Nat Rev Clin Oncol. 2017;14(2):100-113.
Manier S, Powers JT, Sacco A good, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Yards, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro Have always been, Daley GQ, Ghobrial I’m. The newest LIN28B/let-eight axis was a novel therapeutic path from inside the multiple myeloma. Leukemia. 2017;31(4):853-860.
Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco An excellent, Roccaro Are, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Elizabeth, Trippa L, Ghobrial I am. Prognostic part from circulating exosomal miRNAs for the multiple myeloma. Bloodstream. 2017;129(17):2429-2436.
TET2 exon 2 skipping was a different advantageous prognostic basis for cytogenetically normal serious myelogenous leukemia (AML): TET2 exon dos skipping when you look at the AML
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brownish Le, Gray N, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial I am. Inhibiting the newest oncogenic interpretation system is an effective healing means for the multiple myeloma. Sci Transl Med. 2017;9(389).
Magnez Roentgen, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 joining degree having fun with microscale thermophoresis. Sci Rep. 2017;7(1):17623.
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A beneficial, Dumezy F, Feuillard J, Genevieve F, Guerin Age, Man J, Jouault H, Lepelley P, Maynadie Meters, Solly F, Ballon OW, Preudhomme C, Baruchel An excellent, Dombret H, Ifrah N, Bene MC. Prognostic worth of multicenter move cytometry harmonized comparison out of minimal recurring situation inside the acute myeloblastic leukemia. Hematol Oncol. 2017.